Quantum-Si incorporated

NasdaqGM:QSI Voorraadrapport

Marktkapitalisatie: US$187.5m

Quantum-Si Beheer

Beheer criteriumcontroles 3/4

De CEO Quantum-Si is Jeff Hawkins, benoemd in Oct2022, heeft een ambtstermijn van 3.58 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 3.18M, bestaande uit 19.5% salaris en 80.5% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.3% van de aandelen van het bedrijf, ter waarde $ 568.21K. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.3 jaar en 3 jaar.

Belangrijke informatie

Jeff Hawkins

Algemeen directeur

US$3.2m

Totale compensatie

Percentage CEO-salaris19.50%
Dienstverband CEO3.6yrs
Eigendom CEO0.3%
Management gemiddelde ambtstermijn3.3yrs
Gemiddelde ambtstermijn bestuur3yrs

Recente managementupdates

Recent updates

Analyseartikel • May 07

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made...
Analyseartikel • Dec 13

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Invest In Growth?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Seeking Alpha • Oct 27

Quantum-Si: Critical 12 Months Ahead

Summary Quantum-Si's fundamentals are weak at the moment, and this likely extends beyond market conditions. This hasn't mattered to the stock, as Quantum-Si's share price is being driven more by sentiment and quantum hype than financial performance. The Proteus system could alter the trajectory of the business, but technology risk is high and there is competition. While I am negative on QSI's prospects, shorting the stock is risky given the company's cash balance, potential positive news on Proteus and rebounding biopharma demand. Read the full article on Seeking Alpha
Analyseartikel • Jun 26

We're Hopeful That Quantum-Si (NASDAQ:QSI) Will Use Its Cash Wisely

We can readily understand why investors are attracted to unprofitable companies. By way of example, Quantum-Si...
Seeking Alpha • Mar 11

Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet

Summary Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting a significant improvement in performance will be needed to drive wider adoption. Quantum-Si believes that it can introduce a superior system in the next few years, but this involves significant uncertainty. The recent surge in Quantum-Si's share price appears to have been driven more by quantum computing hype than the fundamentals of its business. Read the full article on Seeking Alpha
Seeking Alpha • Jan 04

Quantum-Si: Another Wrong Horse On The Quantum Computing Racetrack - Sell

Summary Similar to data storage solutions provider Quantum Corporation, life sciences company Quantum-Si appears to be have been picked as a quantum computing play solely due to its name. Since listing on Nasdaq in a backdoor IPO almost four years ago, the company has burned almost $350 million in cash and remains way behind its original business plan. However, Quantum-Si has managed to capitalize on the hype by raising additional funds, thus extending its cash runway by more than one year to late 2027. With the company not involved in quantum computing, I would expect momentum traders to leave for assumed greener pastures sooner rather than later. As a result, I am initiating Quantum-Si's common stock with a "Sell" rating. Read the full article on Seeking Alpha
Seeking Alpha • Dec 29

Quantum-Si Isn't A Quantum Computing Company, And Shares Are Overvalued

Summary Quantum-Si has seemingly surged as part of the quantum computing trend, but its own operating business is not focused on quantum computing. Quantum-Si has badly missed its initial SPAC projections and is struggling to gain commercial momentum. Quantum-Si's balance sheet is healthy for now, but it will likely need more cash by the end of 2026 to commercialize its Platinum platform. Given the unproven business model and potential for a secondary offering, traders would be wise to exit positions now. Read the full article on Seeking Alpha
Seeking Alpha • Dec 16

Quantum-Si: Lack Of Commercial Traction Despite Product Upgrades

Summary Quantum-Si (QSI) has made significant progress in technology and management but missed revenue forecasts for 2024, leading to a revised hold rating. Key partnerships with Nvidia, Planet Innovations, and SkyWater aim to enhance product capabilities, particularly with the upcoming Proteus platform. Despite promising advancements, QSI's commercial traction remains insufficient, delaying profitability and necessitating potential capital raises within two years. The product development roadmap is strong, but substantial revenue growth is crucial for QSI to achieve long-term success and profitability. Read the full article on Seeking Alpha
Seeking Alpha • Nov 26

Quantum-Si Is Too Speculative For Me (Technical Analysis)

Summary Quantum-Si has shown bullish price action recently, but I remain skeptical due to its history of bearish trends and potential for a pullback. Short-term momentum is bullish on Quantum-Si stock, but long-term momentum remains bearish, as indicated by the Percentage Price Oscillator (PPO) readings. Volume activity is highly bullish, showing significant institutional interest, yet relative strength remains bearish compared to the S&P 500 index. I recommend waiting for QSI stock to stabilize below the 30-week EMA without making new lows, then reassessing for long-term bullish momentum and institutional buying. Read the full article on Seeking Alpha
Analyseartikel • Nov 06

Is Quantum-Si (NASDAQ:QSI) In A Good Position To Deliver On Growth Plans?

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analyseartikel • Aug 03

Here's Why We're Watching Quantum-Si's (NASDAQ:QSI) Cash Burn Situation

We can readily understand why investors are attracted to unprofitable companies. For example, although...
Analyseartikel • Apr 19

Quantum-Si (NASDAQ:QSI) Is In A Good Position To Deliver On Growth Plans

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Seeking Alpha • Feb 05

Quantum-Si: Commercial Lift Imminent

Summary Quantum-Si is about to move from a controlled launch to a full scale commercial launch of its first product. It will be a groundbreaking device, a desktop Proteome sequencer at a fraction of the price of competing technology. If the product is successful, QSI stock is likely significantly undervalued. Read the full article on Seeking Alpha
Analyseartikel • Dec 04

Companies Like Quantum-Si (NASDAQ:QSI) Are In A Position To Invest In Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Analyseartikel • Jun 28

We Think Quantum-Si (NASDAQ:QSI) Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, biotech and mining...
Seeking Alpha • Oct 04

Jeff Hawkins is the new CEO of Quantum-Si

Quantum-Si (NASDAQ:QSI) appoints veteran life sciences executive Jeff Hawkins as Chief Executive Officer effective October 10, 2022, succeeding Dr. Jonathan Rothberg, Interim Chief Executive Officer, Founder and Executive Chairman. Most recently Jeff Hawkins was President and Chief Executive Officer of Truvian Sciences.
Seeking Alpha • Sep 24

Quantum-Si: Semiconductor-Based Next Generation Protein Sequencing Platform

Novel semiconductor-based next generation protein sequencing platform targeting $64B+ proteomics market in 2024 (15% CAGR). Founded by Dr. Jonathan Rothberg, Professor of Genetics at Yale University (who sequenced the first human genome and is known for inventing high-speed, next-generation DNA sequencing). The company is planning to commercialize its platform next year and could occupy 10% or more of the proteomics market in 5 years, reaching 10x upside in 5-10 years.

Analyse CEO-vergoeding

Hoe is Jeff Hawkins's beloning veranderd ten opzichte van Quantum-Si's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2026n/an/a

-US$104m

Dec 31 2025US$3mUS$621k

-US$101m

Sep 30 2025n/an/a

-US$117m

Jun 30 2025n/an/a

-US$106m

Mar 31 2025n/an/a

-US$101m

Dec 31 2024US$4mUS$596k

-US$101m

Sep 30 2024n/an/a

-US$90m

Jun 30 2024n/an/a

-US$89m

Mar 31 2024n/an/a

-US$92m

Dec 31 2023US$1mUS$575k

-US$96m

Sep 30 2023n/an/a

-US$107m

Jun 30 2023n/an/a

-US$114m

Mar 31 2023n/an/a

-US$121m

Dec 31 2022US$8mUS$132k

-US$132m

Compensatie versus markt: De totale vergoeding ($USD 3.18M ) Jeff } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 1.74M ).

Compensatie versus inkomsten: De vergoeding van Jeff is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Jeff Hawkins (47 yo)

3.6yrs
Tenure
US$3,183,693
Compensatie

Mr. Jeffrey Alan Hawkins, also known as Jeff, serves as Chief Executive Officer at Quantum-Si incorporated since joining from October 10, 2022 and serves as its Director since October 2022 also serves as i...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Jeffry Keyes
CFO & Treasurer3yrsUS$1.66m0.16%
$ 296.1k
John Vieceli
Chief Product Officer1.8yrsUS$1.46m0.076%
$ 143.3k
Todd Rearick
Chief Technology Officer7.3yrsgeen gegevensgeen gegevens
Christian Lapointe
General Counsel & Corporate Secretary5.5yrsUS$2.07m0.22%
$ 413.2k
Lindsay Thompson
Chief Human Resources Officer1.8yrsgeen gegevensgeen gegevens
3.3yrs
Gemiddelde duur
52yo
Gemiddelde leeftijd

Ervaren management: Het managementteam van QSI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.3 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jeffrey Hawkins
President3.6yrsUS$3.18m0.30%
$ 568.2k
Jonathan Rothberg
Founder & Executive Directorno dataUS$195.00k15.45%
$ 29.0m
Kevin Rakin
Independent Director5.9yrsUS$203.13k0.0094%
$ 17.7k
Brigid Makes
Independent Director4.9yrsUS$208.75k0.0094%
$ 17.7k
Ruth Fattori
Independent Director5.2yrsUS$213.75k0.078%
$ 146.8k
Charles Kummeth
Independent Chairman2yrsUS$245.00k0.39%
$ 736.1k
Scott Mendel
Independent Director3yrsUS$211.25k0.065%
$ 122.1k
Amir Jafri
Independent Director2.7yrsUS$207.50k0.053%
$ 99.8k
Paula Dowdy
Independent Director2.2yrsUS$202.81k0.12%
$ 231.7k
John Kenny
Independent Director3yrsUS$212.50k0.052%
$ 98.4k
Gloria Sheynkman
Chair of the Scientific Advisory Board1.3yrsgeen gegevensgeen gegevens
Benjamin Garcia
Member of the Scientific Advisory Board1.3yrsgeen gegevensgeen gegevens
3.0yrs
Gemiddelde duur
60.5yo
Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van QSI wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2026/05/20 13:39
Aandelenkoers aan het einde van de dag2026/05/20 00:00
Inkomsten2026/03/31
Jaarlijkse inkomsten2025/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen over hoe je onze rapporten kunt gebruiken en tutorials op YouTube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Quantum-Si incorporated wordt gevolgd door 3 analisten. 3 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Scott HenryAlliance Global Partners
Kyle MiksonCanaccord Genuity
Swayampakula RamakanthH.C. Wainwright & Co.